abstract |
The present invention relates to humanized anti-human factor D monoclonal antibodies, nucleic acid and amino acid sequences thereof, cells and vectors comprising the same, and their preparation for the treatment of diseases and conditions associated with excessive or uncontrolled complement activation. Use in medicine. These antibodies can be used to diagnose, prevent, and treat diseases. |